As of May 24
| +0.15 / +1.04%|
The 7 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 39.00 and a low estimate of 18.00. The median estimate represents a +85.95% increase from the last price of 14.52.
The current consensus among 9 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.